Max Robotics — Global Service Robot Directory + US Certification

About

Fred Saad is a leading surgical oncologist whose research focuses on optimizing outcomes in robotic and open surgical approaches for major cancers, particularly urological malignancies. His work has significantly advanced the understanding of cost-effectiveness and patient-specific risks in cancer surgery. In a landmark 2025 study, Saad systematically compared the costs of robot-assisted versus open procedures across five major cancers, providing crucial data for healthcare resource allocation. He has also pioneered investigations into adverse in-hospital outcomes following robot-assisted radical cystectomy, specifically comparing extracorporeal and intracorporeal urinary diversion techniques. Notably, Saad’s research extends to vulnerable populations, as demonstrated by his analysis of robot-assisted versus open radical cystectomy outcomes in octogenarians versus younger patients. With over 13 citations to his most recent works, Saad’s contributions are shaping evidence-based surgical decision-making, highlighting the importance of tailoring approaches to individual patient demographics and procedural complexities. His work is essential reading for surgeons and researchers seeking to balance innovation, cost, and safety in oncologic surgery.